Problems › Where Should We Invest Next? › Banks & Financial Services
Capital allocation goes wrong when the loudest line gets funded rather than the one with the best return on the next dollar. This page works through it for banks and financial services firms specifically — including an unedited excerpt from a real analysis of a bank.
Capital allocation goes wrong when the loudest line gets funded rather than the one with the best return on the next dollar. Banks and financial services firms carry a specific bind here — the branch network is simultaneously the deposit moat and the cost problem — and the relationship knowledge sits in six people close to retirement. Until that is priced, efficiency ratio will keep moving for reasons nobody can attribute, and the debate about return by line will stay a matter of opinion.
Most businesses allocate by history and by advocacy: the lines that got money last year get it again, and the person who argues best gets the increment. Neither has anything to do with where the next dollar earns most.
The analysis that helps ranks each line on two things — what it returns on incremental investment, and how durable that return is. A line that returns well but decays in eighteen months is a different proposition from one that returns modestly for a decade, and treating them as comparable is how businesses end up funding decline.
The output should be a sequence with a stopping rule, not a budget split. Which one first, what it funds next, and the observation that would say the sequence is wrong.
These three together are the signature. One on its own usually points somewhere else.
✓ Budgets are set by last year plus a percentage
✓ Nobody can rank the lines by return on incremental investment
✓ Investment decisions are defended by strategic importance rather than by arithmetic
The move that usually makes it worse. Spreading capital evenly to keep the peace, which underfunds the one thing that would have compounded.
It is for you if you run or finance a bank and budgets are set by last year plus a percentage. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a bank. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Harborline Financial Group, a sample company profile used for testing rather than a customer — $3.1B commercial lending book, $410M of deposits.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Codify retiring leaders' knowledge into digital workflows to protect $3.1B book and $2.87M annual funding-cost savings.
The leak it closes. Prevents value transfer to competitors when regional leaders retire; codifies $180M annual origination capacity
The assumption it rests on. Two-leader pilot achieves ≥20% time-to-decision reduction by Month 6 — the engine put the probability at 0.75.
| Investment required | $2–4M over 36 months ($0.8M Phase 1, $1.5M Phase 2, $0.7–1.7M Phase 3) |
| Expected return | 1.4–2.5× over three years (derived: $5.9–7.9M cumulative benefit vs $2–4M investment) |
| Revenue, year 1 | $0.3–0.5M incremental (pilot retention lift) |
| Revenue, year 2 | $1.2–1.8M (full six-leader rollout) |
| Revenue, year 3 | $2.1–3.2M (overlap preservation + new origination) |
| Exit criteria | Abandon if pilot shows <10% time-to-decision reduction OR if overlap falls below 60% by Month 12; reallocate remaining budget to wealth partnership acceleration. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For banks and financial services firms it works through efficiency ratio, cost of funds, origination per banker and deposit concentration, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Price the durability explicitly. A return that decays needs a stated half-life; once each option carries one, options with different horizons become comparable rather than a matter of taste.
Usually the strongest, because that is where a marginal dollar compounds. Fixing the weakest is worth doing when it is a constraint on the strongest, and not otherwise.
Then decide on reversibility. When two options return similarly, take the one you can stop, because the value of the information you buy exceeds the difference in the estimates.
Materially, yes. The branch network is simultaneously the deposit moat and the cost problem — and the relationship knowledge sits in six people close to retirement — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are efficiency ratio, cost of funds, origination per banker, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on efficiency ratio and cost of funds. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.